Survivor Profile

Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.

by Bradley Jones

Forward Look

Cellular immunotherapies can offer periods when people do not require treatment.

by Christina Bennett

Forward Look

Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.

by Kris Conner

Q&A

When Liza Marshall was diagnosed with stage III breast cancer, she and her husband, oncologist John Marshall, had to chart new waters.

by Marci A. Landsmann

Forward Look

Over a decade after human papillomavirus vaccines first became available in the U.S., their effect on cervical cancer incidence is becoming apparent.

by Carisa D. Brewster

Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

by Laurie Adami

Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.

by Anna Goshua

Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.

by Kate Yandell

Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments.

by Jen Tota McGivney

Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.

by Marcus A. Banks